CARNITOR INJECTION Rx
Generic Name and Formulations:
Levocarnitine 1g/5mL; soln for IV bolus inj or infusion; preservative-free.
Leadiant Biosciences, Inc.
Indications for CARNITOR INJECTION:
Secondary carnitine deficiency. Carnitine deficiency in end stage renal disease (ESRD) patients undergoing dialysis.
Adults and Children:
Secondary carnitine deficiency: 50mg/kg as slow (2–3mins) IV bolus inj or infusion; usual max 300mg/kg. May give loading dose in severe metabolic crisis: see full labeling. ESRD: initially 10–20mg/kg dry body weight as slow (2–3mins) IV bolus inj into venous return line after each dialysis session; adjust dose based on trough levocarnitine levels.
Obtain baseline carnitine level; monitor blood chemistry, carnitine levels, vital signs, clinical condition. Seizure disorders. Renal insufficiency (oral forms). Pregnancy. Nursing mothers: not recommended.
Monitor INR with warfarin.
GI upset/pain, body odor, seizures; hypersensitivity reactions (discontinue if occur). Inj: also inj site reactions.
Tabs—90; Oral soln—118mL; Single-dose vials (5mL)—5
Neurology Advisor Articles
- Higher Levels of Cholesterol May Protect Men From Parkinson Disease
- Ajovy Injection Approved for Migraine Prevention in Adults
- Chronic Pain May Be Contributor to Suicide
- FDA Approves Tiglutik for the Treatment of Amyotrophic Lateral Sclerosis
- Natalizumab Improves Cognitive Function in Multiple Sclerosis
- 5 Key Findings Presented at 2018 Parkinson Disease Conference
- Parkinson Disease and the Gut: Treatment Potential Abounds
- Managing Comorbid Migraine and Mood Disorders: A Synergistic Approach
- Stroke-Code Patients With Low NIHSS Score, No Acute Imaging Findings Often Misdiagnosed
- Ethical Challenges of Nusinersen: Considerations When Counseling on Treatment
- New 15-Item Dyspnea-ALS-Score Assesses Dyspnea in ALS
- CDC: About One in Five U.S. Adults Have Chronic Pain
- Fingolimod Cuts Multiple Sclerosis Relapses in Pediatric Patients
- Gains in Insurance Coverage Seen for Lesbian, Gay, Bisexual Adults
- Brivaracetam Effective for Reducing Seizures in Patients with Epileptic Encephalopathies